Search

Purpose. The objective of the present study was to provide an update on the 16 sports with the highest incidence of brain injuries. Thereafter, its diagnosis, treatment, and management strategies are discussed. Methods: The manuscript addresses the brain-related injuries individually in each of the 16 sports with the highest incidence. To simplify the reading, the mentioned 16 sports are sorted alphabetically. A subpart mentioning the management of brainrelated sports injuries, including pharmacological management, is also included in the manuscript. Results: The incidence of sports-mediated brain injuries within hospital-based studies ranged between 3.5 and 31.5 per 100,000. One community-based study using multiple case ascertainment sources identified a higher incidence of 170 per 100,000. Brain injuries due to sports total 1.2-30.3% of all TBIs (traumatic brain injuries). Men have a higher prevalence than women (75.6% vs. 66.1%), and adolescents and young adults had the highest incidence of sports-mediated brain injuries. Almost 50% of head injuries reported during the practice of sports or recreational activities occur in bicycling, skateboarding, or skating incidents. More than 775,000 children, aged 14 and younger, are treated yearly in hospital emergency rooms for sports-related injuries. Conclusions: Brain injuries are common in sports and difficult to manage, but athlete health and injury prevention should be the priority. Preventive measures should be stricter in sports with a higher incidence of brain injury. As for treatment, a comprehensive approach should be adopted. [ABSTRACT FROM AUTHOR]

Background and purpose: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that primarily affects adults, characterized by muscle weakness resulting from the specific death of motor neurons in the spinal cord and brain. The pathogenesis of ALS is associated with the accumulation of mutant superoxide dismutase 1 (SOD1) proteins and neurofilaments in motor neurons, highlighting the critical need for disease‐modifying treatments. Current therapies, such as riluzole and edaravone, provide only symptomatic relief. Recently, tofersen gained approval from the US FDA under the brand name Qalsody as the first and only gene therapy for ALS, addressing a significant pathological aspect of the disease. Methods: We carried out a literature survey using PubMed, Scopus, National Institutes of Health, and Biogen for articles published in the English language concerned with "amyotrophic lateral sclerosis", pathophysiology, current treatment, treatment under clinical trial, and the newly approved drug "tofersen" and its detailed summary. Results: A comprehensive review of the literature on the pathophysiology, available treatment, and newly approved drug for this condition revealed convincing evidence that we are now able to better monitor and treat ALS. Conclusions: Although treatment of ALS is difficult, the newly approved drug tofersen has emerged as a potential therapy to slow down the progression of ALS by targeting SOD1 mRNA, representing a significant advancement in the treatment of ALS. [ABSTRACT FROM AUTHOR]

Today people are focused on their health, as good health is a key to the happiness of our life. Medicine takes a big responsibility to take care of our health. Various supplements are available to meet the nutritional requirement. One such supplement is a combination of piperine and coenzyme Q10. The medicines have to be analyzed properly before introducing them to the market. As no analytical method is available for simultaneous estimation of the combination, hence an attempt was made to develop a validated method for the estimation of piperine and coenzyme Q10 simultaneously in bulk and its dosage form. A simple, precise, accurate and validated reversed phase high performance liquid chromatography technique was developed for the estimation of piperine and coenzyme Q10 in bulk and its tablet formulation. In this developed method, Waters X Bridge C18 column (250 mm×4.6 mm, 5 μm) was used as a stationary phase and acetonitrile, tetrahydrofuran and water was used in 65:32:3 (v/v) ratio as mobile phase with 1 ml/min flow rate. This isocratic separation was accomplished using Waters 2707 Autosampler high performance liquid chromatography system, Waters 515 solvent delivery system, with photodiode array detector detection at 275 nm. Chromatographic data was processed by Empower 2 software. The retention times of coenzyme Q10 and piperine were 4.56 and 8.19 min respectively. The linearity ranges have lied between 4-6 μg/ml, 240-360 μg/ml for piperine and coenzyme Q10 respectively with 0.997 as correlation coefficient for both. [ABSTRACT FROM AUTHOR]